Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: President
Antonio Raviele is President and Contact of the Venice Arrhythmias Scientific Secretariat - the renowned congress of arrhythmology he created in 1989. Between 2008 and 2011 he was Director of the Cardiovascular Department of the Angelo dell'Angelo Hospital. Following his retirement, he practices cardiologist and arrhythmologist at his private practice in Mestre. He was the author of the first… View more
Author(s): Reinoud Knops Added: 3 years ago
Dr Reinoud Knops (Academic Medical Center, Amsterdam, NL) discusses 4 years results from A Randomized Trial Of Subcutaneous Versus Transvenous Defibrillator Therapy: The PRAETORIAN Trial. Questions: 1. Why is PRAETORIAN needed? 2. What was the design, population and endpoints of the study? 3. How long will patients be followed? 4. Were all objectives met? 5. What conclusions should be… View more
Author(s): Justin Hayase , Duc H Do , Noel G Boyle Added: 3 years ago
The ICD is an important therapy for both primary and secondary prevention of sudden cardiac death in selected patients. The role for defibrillation threshold (DFT) testing either intraoperatively or postoperatively has changed significantly over the past few decades, and it is no longer routinely recommended in patients undergoing left-sided transvenous ICD implantation.1–7 The definition of the… View more
Author(s): Adryan A Perez , Frank W Woo , Darren C Tsang , et al Added: 3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–­1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia… View more
Author(s): Dietmar Bänsch Added: 3 years ago
For more than three decades, the implantable cardioverter defibrillator (ICD) has proven to be a well-established, main therapeutic tool for the primary and secondary prevention of sudden cardiac death due to malignant ventricular arrhythmias.1 One of the standard practice concepts is defibrillation (DF) testing. Defibrillation testing has been considered a mandatory part at the time of… View more
Author(s): Hussam Ali , Pierpaolo Lupo , Riccardo Cappato Added: 3 years ago
Numerous large clinical trials have demonstrated the benefit of implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death (SCD) in selected populations.1,2 These results and advances in defibrillation therapies have led to an impressive expansion of ICD implants and indications in recent decades. Although initially focusing on secondary prevention, current ICD indications… View more